HemaSphere Podcast
Autor: HemaSphere Journal
HemaSphere is the official online, open access journal of the European Hematology Association (EHA). HemaSphere publishes exciting basic, translational, and clinical research in hematology. We are pleased to introduce our new podcast series where our host and guest speakers exchange ideas about select HemaSphere publications. Spend some time with us and enjoy casual and insightful discussions about hematology research. Listen to the stories behind the papers. HemaSphere is always accessible; our full range of open access publications is available at www.hemaspherejournal.com.
Odcinki
- CAR T From Within - Vilcot, Brugère, Fuentealba, Houot – HemaSphere Podcast
- Why More Mitochondrial DNA Mutations Can Mean a Better Outcome - Dr Ilaria Pagani – HemaSphere Podcast
- Why Inflammatory Signaling Holds the Key to Durable MDS Therapies - Dr Manja Wobus, Dr Katja Sockel – HemaSphere Podcast
- p53 in Cancer: Dual Threat - Dr Isabelle Plo, Dr Barbara Monte-Mór – HemaSphere Podcast
- Blinatumomab in De Novo AYA ALL - Dr Matthew Greenwood – HemaSphere Podcast
- Inequalities in sickle cell therapies - Dr Stephen Hibbs, Dr Paul Telfer, Mary-Shaniqua - Patient Advocate – HemaSphere Podcast
- Defining Lineage in Ambiguous Leukemia: A Transcriptomic View - Dr. Anikó Sijs-Szabó & Roger Mulet Lázaro, PhD – HemaSphere Podcast
- EHA/EBMT Survey on Grading and Management of ICAHT - Dr Kai Rejeski – HemaSphere Podcast
- Tackling NUP98 Rearranged AML in Pediatric Oncology - Prof Michel Zwaan, Prof Olaf Heidenreich – HemaSphere Podcast
- Part 2 - Metabolism in hematology - Ep 3.4 – HemaSphere Podcast
- Part 1 - Metabolism in hematology - Ep 3.4 – HemaSphere Podcast
- Machine learning for AML-MRD - Ep 3.3 – HemaSphere Podcast
- 2 of 2: Navigating Neutropenia: New Guidelines Explained - Ep 3.2 – HemaSphere Podcast
- Single‐cell DNA and surface protein - Ep 3.1 – HemaSphere Podcast
- Two distinct fetal-type signatures characterize JMML - Ep 2.8 – HemaSphere Podcast
- Revolutionizing Pediatric Cancer Research with PDXs - Ep 2.7 – HemaSphere Podcast
- High 5hmC predicts worse OS - Ep 2.6 – HemaSphere Podcast
- Informed consent is almost impossible - Ep 2.5 – HemaSphere Podcast
- Best of Pediatric Hematology from EHA2024 - Ep 2.4 – HemaSphere Podcast
- NOTCH1 fusions in T‐LBL - Ep 2.3 – HemaSphere Podcast
- A transcriptional cofactor‐mediated dependency module - Ep 2.2 – HemaSphere Podcast
- Unraveling the secrets of thrombopoiesis - Ep 2.1 – HemaSphere Podcast
- What’s so Great About the P-value? A Statistician’s Point of View - Ep 1.8 – HemaSphere Podcast
- This Is Going to Hurt: Revisiting the Patient Experience of Bone Marrow Biopsies - Ep 1.7 – HemaSphere Podcast
- 1 of 2: The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children - Ep 1.6 – HemaSphere Podcast
- Part 1 - Comprehensive Diagnosis and Management of POEMS Syndrome - Ep 1.4 – HemaSphere Podcast
- Part 2 - Comprehensive Diagnosis and Management of POEMS Syndrome - Ep 1.5 – HemaSphere Podcast
- Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis - Ep 1.3 – HemaSphere Podcast
- EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer - Ep 1.2 – HemaSphere Podcast
- Long COVID-19” of Researchers: What to Do Next? - Ep 1.1 – HemaSphere Podcast